Valeo Pharma (TSE:VPH) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Valeo Pharma Inc., a Canadian pharmaceutical firm, is delisting its Class A shares from the OTCQB Venture Market due to low trading volume and high costs, focusing instead on the TSX and FSE markets. This strategic move, aimed to consolidate trading platforms, was announced by CEO Al Moghaddam, highlighting the TSX’s senior status and advanced trading system.
For further insights into TSE:VPH stock, check out TipRanks’ Stock Analysis page.